|
1
|
Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer.
|
Nat Med
|
1996
|
2.42
|
|
2
|
Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants.
|
Addict Biol
|
2004
|
2.14
|
|
3
|
Intraventricular neurocytoma.
|
Australas Radiol
|
1996
|
1.93
|
|
4
|
Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.
|
J Pathol
|
1998
|
1.64
|
|
5
|
CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity.
|
Am J Psychiatry
|
1990
|
0.91
|
|
6
|
Sublingual capnometry and indexes of tissue perfusion in patients with circulatory failure.
|
Chest
|
2001
|
0.89
|
|
7
|
Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
|
J Clin Psychopharmacol
|
1987
|
0.80
|
|
8
|
The severity of alpha-particle-induced DNA damage is revealed by exposure to cell-free extracts.
|
Radiat Res
|
1996
|
0.78
|
|
9
|
Age differences in retention of concurrent discrimination problems in monkeys.
|
J Gerontol
|
1973
|
0.76
|
|
10
|
A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
|
Am J Drug Alcohol Abuse
|
2007
|
0.76
|
|
11
|
Dermatology-trained practice nurses.
|
Br J Gen Pract
|
2000
|
0.75
|
|
12
|
Cycles of dose-intensive chemotherapy with peripheral stem cell support in persistent or recurrent platinum-sensitive ovarian cancer.
|
Gynecol Oncol
|
1997
|
0.75
|
|
13
|
Cystic cerebellar schwannoma: case report.
|
Neurosurgery
|
1991
|
0.75
|
|
14
|
R.Y. McKenzie: a great man to remember in Canada's Olympic year.
|
Can Med Assoc J
|
1976
|
0.75
|
|
15
|
Expression of matrix metalloproteinases in colorectal cancer.
|
Biochem Soc Trans
|
1996
|
0.75
|